News

Nonwhite Parkinson’s patients see worse HRQoL than white patients

Black, Hispanic, and Asian people with Parkinson’s disease report lower health-related quality of life (HRQoL) than their white counterparts, a recent study showed. Differences in cognitive performance were found to partly underlie these disparities. The study, “Racial and Ethnic Differences in Health-Related Quality of Life for Individuals with…

Faster gains seen with home apomorphine infusion in Parkinson’s

Home initiation of under-the-skin (subcutaneous) apomorphine infusion — a treatment for motor fluctuations — is faster at improving the life quality of Parkinson’s disease patients than in hospital initiation, a French study has shown. Continuous subcutaneous apomorphine infusion (CSAI) initiation at home for Parkinson’s was found to be feasible…

Exercise interventions found to ease motor symptoms in Parkinson’s

Physical exercise interventions can lessen Parkinson’s disease motor symptoms — and these beneficial effects are similar for both aerobic and nonaerobic activity. That’s according to the findings of a new meta-analysis of published studies, which involved 25 articles relating to interventions spanning 4-26 weeks. “This review provides…

National Plan to End Parkinson’s Act reintroduced

With bipartisan support, the National Plan to End Parkinson’s Act has been reintroduced in the U.S. House and Senate. The legislation aims to unite the federal government in a coordinated effort with the private sector to cure and prevent the neurodegenerative disease. Said to be the first legislation devoted…

Dipraglurant eases motor, nonmotor symptoms in rodents

Dipraglurant, an investigational oral therapy from Addex Therapeutics, eased motor and nonmotor symptoms associated with Parkinson’s disease in rodent models, a study showed. Along with being rapidly absorbed in the bloodstream, dipraglurant demonstrated anti-parkinsonian effects and reduced behaviors associated with anxiety, depression, and obsessive-compulsive disorder in mice and…